Clinical practice guidelines for the management of atopic dermatitis 2018

Norito Katoh, Yukihiro Ohya, Masanori Ikeda, Tamotsu Ebihara, Ichiro Katayama, Hidehisa Saeki, Naoki Shimojo, Akio Tanaka, Takeshi Nakahara, Mizuho Nagao, Michihiro Hide, Yuji Fujita, Takao Fujisawa, Masaki Futamura, Koji Masuda, Hiroyuki Murota, Kiwako Yamamoto-Hanada

研究成果: ジャーナルへの寄稿学術誌査読

57 被引用数 (Scopus)


Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.

ジャーナルJournal of Dermatology
出版ステータス出版済み - 12月 1 2019

!!!All Science Journal Classification (ASJC) codes

  • 皮膚病学


「Clinical practice guidelines for the management of atopic dermatitis 2018」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。